Mork Family Department of Chemical Engineering and Materials Science, University of Southern California, Los Angeles, CA 90089, USA.
Immunol Rev. 2011 Jan;239(1):45-61. doi: 10.1111/j.1600-065X.2010.00967.x.
The increasing level of understanding of the lentivirus biology has been instrumental in shaping the design strategy of creating therapeutic lentiviral delivery vectors. As a result, lentiviral vectors have become one of the most powerful gene transfer vehicles. They are widely used for therapeutic purposes as well as in studies of basic biology, due to their unique characteristics. Lentiviral vectors have been successfully employed to mediate durable and efficient antigen expression and presentation in dendritic cells both in vitro and in vivo, leading to the activation of cellular immunity and humoral responses. This capability makes the lentiviral vector an ideal choice for immunizations that target a wide range of cancers and infectious diseases. Further advances into optimizing the vector system and understanding the relationship between the immune system and diseases pathogenesis will only augment the potential benefits and utility of lentiviral vaccines for human health.
对慢病毒生物学的理解水平不断提高，这对创造治疗性慢病毒传递载体的设计策略产生了重大影响。因此，慢病毒载体已成为最强大的基因转移载体之一。由于其独特的特性，它们被广泛用于治疗目的以及基础生物学研究。慢病毒载体已成功用于在体外和体内介导树突状细胞中持久和有效的抗原表达和呈递，从而激活细胞免疫和体液反应。这种能力使慢病毒载体成为针对广泛的癌症和传染病的免疫接种的理想选择。进一步优化载体系统并深入了解免疫系统与疾病发病机制之间的关系，将只会增加慢病毒疫苗对人类健康的潜在益处和实用性。
